What was Anbogen Therapeutics, Inc.’s price range in the past 12 months?
Anbogen Therapeutics, Inc. lowest stock price was TWD 7.91 and its highest was TWD 22.45 in the past 12 months.
What is Anbogen Therapeutics, Inc.’s market cap?
Anbogen Therapeutics, Inc.’s market cap is TWD 1.54B.
When is Anbogen Therapeutics, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Anbogen Therapeutics, Inc. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Anbogen Therapeutics, Inc. pay dividends?
Anbogen Therapeutics, Inc. does not currently pay dividends.
What is Anbogen Therapeutics, Inc.’s EPS estimate?
Anbogen Therapeutics, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Anbogen Therapeutics, Inc. have?
Anbogen Therapeutics, Inc. has 187,601,490 shares outstanding.
Which hedge fund is a major shareholder of Anbogen Therapeutics, Inc.?
Currently, no hedge funds are holding shares in TW:7784
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology